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SUMMARY
Bacteria of the genus Bartonella are emerging pathogens detected in lymph node biopsies and aspirates probably caused by 
increased concentration of bacteria. Twenty-three samples of 18 patients with clinical, laboratory and/or epidemiological data suggesting 
bartonellosis were subjected to three nested amplifications targeting a fragment of the 60-kDa heat shock protein (HSP), the internal 
transcribed spacer 16S-23S rRNA (ITS) and the cell division (FtsZ) of Bartonella henselae, in order to improve detection in clinical 
samples. In the first amplification 01, 04 and 05 samples, were positive by HSP (4.3%), FtsZ (17.4%) and ITS (21.7%), respectively. 
After the second round six positive samples were identified by nested-HSP (26%), eight by nested-ITS (34.8%) and 18 by nested-FtsZ 
(78.2%), corresponding to 10 peripheral blood samples, five lymph node biopsies, two skin biopsies and one lymph node aspirate. 
The nested-FtsZ was more sensitive than nested-HSP and nested-ITS (p < 0.0001), enabling the detection of Bartonella henselae 
DNA in 15 of 18 patients (83.3%). In this study, three nested-PCR that should be specific for Bartonella henselae amplification were 
developed, but only the nested-FtsZ did not amplify DNA from Bartonella quintana. We conclude that nested amplifications increased 
detection of B. henselae DNA, and that the nested-FtsZ was the most sensitive and the only specific to B. henselae in different biological 
samples. As all samples detected by nested-HSP and nested-ITS, were also by nested-FtsZ, we infer that in our series infections were 
caused by Bartonella henselae. The high number of positive blood samples draws attention to the use of this biological material in 
the investigation of bartonellosis, regardless of the immune status of patients. This fact is important in the case of critically ill patients 
and young children to avoid more invasive procedures such as lymph nodes biopsies and aspirates.
KEYWORDS: Bartonellosis; Bartonella spp.; Bartonella henselae; Cat Scratch Disease, PCR. 
INTRODUCTION
Bacteria of the genus Bartonella are considered as emerging 
pathogens of increasing importance and worldwide distribution. The 
genus Bartonella includes at least 30 species and subspecies, and around 
12 are human pathogens (BOULOUIS et al., 2005; LAMAS et al., 
2008) responsible for syndromes such as Carrion’s disease caused by 
Bartonella bacilliformis (nonexistent in non Andean countries), trench 
fever by Bartonella quintana, cat-scratch disease (CSD), bacillary 
angiomatosis, along with recurrent bacteremia, septicemia, endocarditis, 
trombocytopenic purpura, erythema multiforme, erythema nodosum, 
severe anemia and peliosis hepatis (BREITSCHWERDT et al., 2010). 
Bartonella henselae is the most frequently identified species in human 
infections (LAMAS et al., 2008; BREITSHWERDT et al., 2010). 
Laboratory diagnosis is based on culture isolation, serology, 
histopathology, and molecular detection mainly in lymph node biopsies 
and aspirates, (which is probably due to a higher concentration of 
bacteria in these specimens), and more rarely in peripheral blood samples 
(HANSMANN et al., 2005; DEL PRETE et al., 2000; ARVAND & 
SCHÄD, 2006). Species identification and differentiation is troublesome 
due to the bacteria’s slow and fastidious growth. At the time of blood 
collection, the level of contamination is between 1 to 10 colony forming 
units/mL thus justifying the failure to isolate or amplify the bacterium DNA 
in blood samples after one-round amplifications (BRECHER et al., 2000). 
In our country, none of the few commercial kits, either serological or based 
on histochemical techniques, are currently available in routine laboratories. 
Conventional one-round PCR targeting different Bartonella genes such 
as the 60kDa heat-shock protein (ANDERSON et al., 1994), the citrate 
synthase enzyme (NORMAN et al., 1995), the 16S rRNA (BIRTLES, 
1995), the 16S-23S intergenic spacer (MINNICK & BARBIAN, 1997) 
and the cell division protein FtsZ (KELLY et al, 1998) reported variable 
sensitivities, although some of the techniques were able to discriminate 
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among species. More recently, a quantitative amplification targeting the 
Bartonella heat-shock protein groEL was used to investigate bacteremia 
levels in serum samples of 18 patients with CSD, however, positive results 
were detected in only three patients (VERMEULEN et al., 2008). 
In the present study, we standardized three nested-PCR targeting the 
60kDa heat-shock protein (ANDERSON et al., 1994), the FtsZ gene 
(KELLY et al., 1998) and the 16S-23S intergenic spacer (MINNICK & 
BARBIAN, 1997) to improve B. henselae DNA detection in different 
biological specimen, including peripheral blood samples of immune 
competent and immune compromised patients. 
PATIENTS, MATERIAL, METHODS
This research was approved by the Institutional Ethics Committee 
(CAPPesq protocol number 1245/2006). Informed consent was obtained 
from all patients, their parents, or legal guardians. 
Twenty three samples from 18 patients with clinical and laboratory 
(n = 5), or only clinical and/or epidemiological suspicion of bartonellosis 
(n = 13) were tested: 13 blood samples, seven lymph node biopsies, two 
skin biopsies and one lymph node aspirate. 
Three milliliters of EDTA whole blood samples or 10 mg of 
skin, lymph node biopsies or aspirates were used for DNA extraction 
(QIAmp or DNeasy & Tissue kit, QIAGEN Inc., USA)., according to 
the manufacturer instructions. 
Amplifications were performed following strict measures to minimize 
the risk of carry over contamination (BURKARDT, 2000). Briefly, 
reactions were set up in three separate rooms containing dedicated 
equipment, supplies and pipetting devices. Reagents and samples were 
handled with disposable gloves, DNA/RNase-free microtubes and 
pipetting tips in safety cabinets equipped with UV lights.
The outer primers (IDT, Iowa-USA) were designed elsewhere 
(ANDERSON et al., 1994; MINNICK AND BARBIAN, 1997; 
KELLY et al, 1998) and the inner primers were designed in our 
laboratory. The nested-HSP was performed with the primers 
forward 5’- AGCTGGTATCAAGGCAGGTG-3’ and reverse 5’- 
ATTTTCGTCTTCAGGCATCG-3’ generating an amplification product 
of 184 bp; the nested-ITS was performed with the primers forward 
5’- GAT GATGATCCCAAGCCTTC-3’ and reverse 5’- TCCCC 
GGCATAATCTCATAA- 3’generating an amplification product of 
113 bp, and the nested-FtsZ was performed with the primers forward 
5’- CAAAACGGTTGGAGAGCAGT-3’ and reverse 5’- CGCCTG 
TCATCTCATCAAGA-3’ generating an amplification product of 218 
bp. Amplifications were carried out in a T3 Thermocycler (Biometra, 
Göttingen, Germany), in a final volume of 50 µL containing 1,000 ng 
of genomic DNA in the first round and 10 µL were transferred onto the 
second round. Other reagent concentrations were: 200 µM of dNTP 
(Labtrade, São Paulo, Brazil), 2.5 U of Taq DNA polymerase (Labtrade, 




0.4 µM of each primer. 
Amplifications consisted of an initial denaturation step of five min at 
95 ºC, 40 cycles of one min at 95 ºC, one min at 60 ºC for nested-HSP and 
nested-FtsZ or 55 ºC for the nested-ITS, one min at 72 ºC, ending with 
a final extension step of five min at 72 ºC. PCR products were detected 
in 2% agarose gels stained with 0.5 µg/mL of ethidium bromide and 
perceived by UV transillumination (Vilber Lourmat, France). In each 
experiment, B. henselae DNA extracted from a purchased ATCC 49882R 
strain (Adolfo Lutz Institute, São Paulo, Brazil) was used as the positive 
control, and two sterile deionized water samples, representing the master 
mix and the DNA extraction room were used as negative controls.
To determine the detection limit, serial dilutions of B. henselae 
DNA, ranging from 1 ng to 1 fg, were spiked with 1,000 ng of DNA 
from a healthy individual. Each dilution was tested 10 times to ensure 
reproducibility. 
Microorganisms that can cause mononucleosis-like syndrome were 
included in the specificity evaluation because they can cause signs and 
symptoms that could be confused with the cat scratch disease or other 
acute infectious diseases: Escherichia coli, Streptococcus pyogenes, 
Staphylococcus epidermidis, Chlamydia pneumoniae, Mycobacterium 
tuberculosis, Cytomegalovirus, Epstein-Barr virus, Toxoplasma gondii, 
as well as four other Bartonella species: B. quintana, B. elizabethae, B. 
vinsonii and B. clarridgeiae. These microorganisms DNA were tested three 
times in different DNA concentrations (100 ng, 500 ng and 1,000 ng). 
Considering that a laboratory investigation of Bartonella spp. 
infection was performed in only five of the 18 patients, the confirmation 
of amplification results was made using RFLP and DNA sequencing, 
planning to adopt the RFLP as the standard confirmatory method in the 
future due to its better cost-effectiveness. In the case of nested-FtsZ, 4 µL of 
the amplification products were digested with 5U of the restriction enzyme 
HpyCH4IV (New England Biolabs, Ipswich, USA) in a final volume of 20 
µL. After an incubation of three hours at 37 ºC, the B. henselae amplification 
product (218 bp) should generate two fragments of 127 and 91 bp. 
The entire nested-FtsZ product was purified (QIAquick PCR 
Purification Kit, QIAgen) and sequenced twice in each direction (ABI-
377, Applied Biosytems Incorporation, Foster City, California, USA). 
The degree of homology between amplified sequences and B. henselae 
Houston-1 strain (GenBank AF061746.1) was assessed by sequence 
alignment using the BLAST software available in http://www.ncbi.nlm.
nih.gov/BLAST. 
Sequence alignment was also used to ensure that the DNA sequence 
amplified by the nested-FtsZ did not present a significant degree of 
homology with the other Bartonella species: B. elizabethae (GenBank 
AF467760.1); B. vinsonii subsp berkoffii (GenBank AF467764.1); 
B. clarridgeiae (GenBank AF141018.1); B. rochalimae SM318006 
(GenBank DQ676490.1) and B. rochalimae HUMBOLT 131 (GenBank 
DQ 676486.1). 
Statistical analysis was performed by SPSS (version 13.0 for 
Windows, SPSS Inc; USA). The frequency of positive results was 
compared for each of the three systems after the first, and after the second 
round of amplification. Considering the three nested-PCR, the frequency 
of positive results was also compared. The agreement or disagreement of 
results was determined by the McNemar test and p values < 0.05 were 





In the present study, three nested-FtsZ-PCR were developed to 
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improve the molecular detection of Bartonella henselae in different 
biological samples, with emphasis on peripheral blood. 
Twenty three samples from 18 patients were tested. Demographic 
data, signs and symptoms, laboratory tests results, antibiotic therapy and 
outcome of patients were summarized in Table 1. As an overview, 11 
patients were female, ages varied from two to 80 years old, 15 had received 
antibiotics, 10 had a fever, 10 confirmed they had contact with cats, nine 
had adenomegaly, eight had underlying diseases, and in two patients the 
disease led to death. The cases of patients numbered 1 and 3 were reported 
elsewhere (VELHO et al., 2007; MAGALHÃES et al., 2010). 
The limiting dilution test revealed that the first round of amplifications 
for each of the three systems (HSP, ITS and FtsZ) consistently detected 
1 pg of B. henselae DNA, and the second round 100 fg. There was no 
cross reactivity with the microorganisms used in the specificity tests, 
including DNA of other three species of Bartonella: elizabethae; vinsonii 
subsp berkoffii; clarridgeiae. However, the nested-HSP and the nested-
ITS yielded a positive, although weak, amplification when the higher 
concentration (1,000 ng) of Bartonella quintana was tested, even though 
the primers design was aimed at amplifying only the species henselae.
The first amplification was positive in one sample by HSP (1/23 
or 4.3%); in four samples by FtsZ (17.4%), and in five samples by 
ITS (21.7%). After the second round, there were six positive samples 
by nested-HSP (26%), and eight by nested-ITS (34.8%), while the 
nested-FtsZ was able to detect 18 samples (78.2%): 10 peripheral 
blood samples, five lymph node biopsies, two skin biopsies and one 
lymph node aspirate. Statistical analysis comparing the frequency of 
positive results after the first and the second round of amplification 
confirmed that the nested amplification was worth performing only for 
the nested-FtsZ (4/23 or 17.4% vs. 18/23 or 78.3%; p = 0.0001), whereas 
there was no statistical significance for the nested-HSP (p = 0.063) or 
the nested-ITS (p = 0.250). Moreover, among the three amplification 
systems, the nested-FtsZ proved to be more sensitive than nested-HSP 
and ITS (p < 0.0001).
RFLP results after digestion of the FtsZ amplification products with 
the enzyme HpyCH4IV are displayed in Figure 1. As expected, all 18 
positive samples generated two fragments of 127 and 91 bp. 
In addition, automated DNA sequencing has confirmed RFLP results, 
i.e., the 18 amplification products were from the B. henselae FtsZ gene, as 
TABLE 1
Demographic and epidemiological data, signs/symptoms, laboratory investigation, treatment and outcome of the 18 patients included in the study
N° A G Underlying 
disease





Laboratory investigation Antibiotics Outcome
1* 36 M Intravenous 
drug addict, 
AIDS
Fever. pulmonary edema, 
bacillary angiomatosis, 
severe anemia, hepatitis, 
peritonitis, pleuritis, peri-
carditis, perianal lesion, 
and skin papule. Contact 




Electron microscopy of the papule 
biopsy showed a double-layered-
bacterium adhered to an erythrocyte. 
Histopathology was suggestive of 
Bartonella spp. Negative blood 
and skin cultures. Negative anti-B. 
henselae and B. quintana serology 
(IFAT-IgG). Positive PCR of the 
papule. DNA sequencing confirmed 
that PCR amplified B. henselae DNA. 




another state and 
he was lost to 
follow-up.
2 14 F none No fever. Angio-
proliferative skin lesion. 
Contact with cats. 
blood Electron microscopy of the skin biopsy 
showed a double-layered-bacteria 
adhered to erytrocytes, Positive anti-
Bartonella IgG (IFAT). The blood 
sample yielded a positive nested-FtsZ-
PCR. The skin lesion was not tested by 
nested-FtsZ-PCR
Erythromycin Full recovery 
*3 27 F none Asymptomatic. Had do-
nated blood (Public Blood 
Bank). Contact with cats.
This woman is the mother 
of patient number 4. 
Blood Optical microscopy of the erythrocytes 
from the blood bag showing bacteria 
adhered to erythrocytes. Blood was 
positive by nested-FtsZ-PCR. 





after six months 
4 3 F Neonatal 
cholestasis 
syndrome 
No fever. anemia, jaun-
dice, hepatosplenomegaly. 
Contact with cats.
Blood IFAT -IgG was negative for Bartonella 
henselae and B. quintana. Electron mi-
croscopy showed double layered- bac-
teria adhered to erythrocytes. The child 
peripheral blood at three years old was 





of infection and 
outpatient clinic 
follow-up 
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N° A G Underlying 
disease





Laboratory investigation Antibiotics Outcome
5 11 M None Fever, hepatomegaly Blood Blood culture identified Bartonella 











Lymph node biopsy and peripheral 
blood were positive by nested-FtsZ-
PCR. 
Cotrimoxazole Full recovery 
7 5 M None Fever, axillary adenomega-
ly. Contact with cats.
Blood Peripheral blood was positive by 
nested-FtsZ-PCR.
Cotrimoxazole Full recovery 
8 9 F None High fever for 3 months 




Lymph node biopsy was positive by 
nested-FtsZ-PCR
Claritromicin Full recovery 
9 8 F None No fever, cervical adeno-




Lymph node aspirate was positive by 
nested-FtsZ-PCR. 
None Full recovery 






Lymph node biopsy and peripheral 





11 6 F None Fever, Contact with cats. 
and antecedent of cat 
scratch two months before
Blood Peripheral blood was positive by 
nested-FtsZ-PCR. 
Cotrimoxazole Full recovery 





Lymph node biopsy was positive by 
nested-FtsZ-PCR
Cotrimoxazole Full recovery 
13 9 F Meningo en-
cephalitis and 
seizures. 
Two months of fever and 
axillary adenomegaly. 
Contact with cats.






14 7 M AIDS, pelio-
sis hepatis 
High and persistent fever, 










15 12 M Chronic 
Granuloma-
tous Disease 






Lymph node biopsy and peripheral 
blood were positive by nested-FtsZ-
PCR. 
Cefalexin Death 
16 61 F Hodgkin 
lymphoma 







Lymph node biopsy and peripheral 






17 80 F Non-Hodgkin 
lymphoma
No fever. Cervical adeno-






Lymph node biopsy and peripheral 










Fever and splenomegaly Blood Staphylococcus coagulase negative 
was isolated from blood. Peripheral 






A = age in years; G = gender (masculine or feminine). * reference VELHO et al., 2007 (case No. 1) and MAGALHÃES et al., 2010 (case No. 3). 
TABLE 1
Demographic and epidemiological data, signs/symptoms, laboratory investigation, treatment and outcome of the 18 patients included in the study (continuation)
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the degree of homology between these 18 PCR products and B. henselae 
Houston-1 strain varied from 97 to 100% (data not shown). 
DISCUSSION
Bartonella spp. isolation and specific IgG detection is available in 
just a few university centers in our country, and therefore in most cases 
the diagnosis of bartonellosis is based on the association of suggestive 
signs and symptoms with at least one of the following parameters: 
epidemiological data reporting contact with animals, especially cats; 
microscopy and/or histological findings (HANSMANN et al., 2005). 
Due to the fact that our patients live in areas with low levels of 
laboratory resources, in a significant amount of cases none of the specific 
tests to diagnose Bartonella spp. infections were performed. In order 
to circumvent the lack of a gold standard in these cases, we confirmed 
that the nested-FtsZ amplifications corresponded to B. henselae DNA 
by using RFLP and DNA sequencing. Due to budget constraints, we 
did not sequence the six nested-HSP positive samples and the eight 
nested-ITS ones. 
It is known that the target gene, the type of biological sample, 
the sample size as well as different DNA extraction protocols can 
dramatically influence amplification results. Only a few studies have 
reported detection of Bartonella spp. DNA in blood samples of CSD or 
immune compromised patients (ARVAND & SCHÄND, 2006; VELHO 
et al., 2007), while the detection in serum samples has so far been 
unsuccessful (VERMEULEN et al., 2008). 
Although the HSP gene primers had already been used to amplify 
lymph node biopsies and secretions by ANDERSON et al. (1994); 
AVIDOR et al. (1997) and HANSMANN et al. (2005) with detection 
rates varying from 69 to 84%, our nested-HSP was the least sensitive of 
the three systems, and yielded positive results with B. quintana DNA, 
even though the primers were designed to amplify only B. henselae. 
GARCIA-ESTEBAN et al. (2008) reported the detection of 
Bartonella by a 16S-23S rRNA intergenic spacer and a multiplex-PCR 
targeting the 16S rRNA gene combined with a reverse line blotting that 
could simultaneously detect around 20 different Bartonella species from 
a number of clinical specimens. In the present study, despite the use of 
a new set of primers of the 16S-23S rRNA intergenic spacer in nested 
amplifications, the sensitivity was low, and there was cross-reactivity 
with B. quintana DNA, as in the case of the nested-HSP amplifications.
EHRENBORG et al. (2000) used different primers of B. henselae 
FtsZ gene in one-round amplifications. They tested 15 biological 
specimens including tissue fragments and blood samples from cats and 
humans, either HIV-positive or with no underlying conditions, and found 
a positivity of 64%. 
The C-terminal end of the FtsZ gene was used to investigate the 
presence of Bartonella spp. DNA in 80 samples (lymph node biopsies, 
lymph node aspirates, heart valve fragments) of patients with CSD and/
or endocarditis by a one-round PCR. They detected 35 positive samples 
(43.75%) in comparison with 39 positive samples (48.75%) by ITS or 
pap31 one-round amplifications (ZEAITER et al., 2002). In the present 
study, the same FtsZ gene region was used to test 23 samples of 18 
patients, 15 of whom had already received antibiotics, but even so the 
nested-FtsZ-PCR was positive in 18 samples of 15 patients. ARVAND 
& SCHÄD (2006) reported detection of B. henselae DNA in a child with 
CSD up to nine weeks after admission and three weeks of antibiotic 
therapy. In this child several blood samples were tested, and they used a 
semi-nested PCR targeting the B. henselae htrA gene. 
Among the five patients with laboratory evidence of Bartonella spp. 
infection (1-5, Table 1), PCR confirmed the diagnosis in all of them 
(four blood samples and one skin biopsy). Patient number one had AIDS 
and patient number 4 was a three year old child with an antecedent of 
neonatal cholestasis syndrome, while the other three patients had no 
underlying conditions. 
The two skin biopsies analyzed in the present study were positive by 
PCR and belonged to AIDS patients (Table 1, number 1 and 14). With 
regards to the seven lymph node biopsies, PCR was positive in five, and 
only one of seven patients (number 15) had a previous medical condition. 
In two patients only the lymph node biopsy was analyzed (number 8 and 
12), and in three patients blood samples were tested in parallel and all 
specimens were positive (number 6, 10 and 15). 
As for the 13 blood samples analyzed in the study, 10 were positive 
(seven of 10 patients had no underlying conditions). The three negative 
blood samples belonged to patients 16 and 17, who were later diagnosed 
with lymphoma, and to patient number 18 who had a staphylococcal 
infection detected by blood culture. Nevertheless, considering that our 
nested-FtsZ is species-specific, it is not possible to rule out the presence 
of other Bartonella species in these patients. 
We conclude that nested amplifications increased the detection of 
B. henselae DNA, and that nested-FtsZ was the most sensitive and the 
only one specific to B. henselae in different biological specimens. Taking 
into account that all samples detected by nested-HSP and nested-ITS 
were also detected by the nested-FtsZ, and that the 18 positive samples 
presented with highly homologous nucleotide sequences in comparison 
with Bartonella henselae Houston-1 strain, we infer that in our series 
all infections were caused by Bartonella henselae. The high positivity 
of blood samples has highlighted the use of this biological material to 
investigate bartonellosis irrespective of the patients’ immune status. This 
is of great importance in critically ill patients and in young children 
where this method can be used in order to avoid more invasive procedures 
such as lymph node biopsies and fine-needle aspirates. Considering that 
nested-amplifications are more prone to carry-over contamination, we 
intend to develop a quantitative diagnostic tool based on the primers 
presented herewith. 
Fig. 1 - RFLP of the 18 positive nested-FtsZ-PCR samples (10 blood samples, 5 lymph node 
biopsies, 2 lymph node aspirates and 1 skin biopsy) after digestion with HpyCH4IV (lanes 
1 to 18). The molecular weight marker (MW) is the 25 base-pair ladder (Invitrogen) and the 
strongest band is 125 base-pairs. C1 displays the amplification product of the Houston-1 
strain after digestion (positive control), generating two fragments of 127 and 91 base-pairs, 
like the 18 positive samples of the study, and C2 exhibits the same positive control prior to 
HpyCH4IV digestion showing the entire fragment of 218 base-pairs.
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RESUMO
Detecção de DNA de Bartonella henselae em amostras clínicas, 
incluindo sangue periférico, de pacientes imunocompetentes e 
imunodeprimidos por meio de três amplificações duplas
Bactérias do gênero Bartonella constituem patógenos emergentes 
detectados em biópsias de linfonodos e secreções de gânglios 
provavelmente devido a maior concentração de bactérias. Vinte e 
três amostras de 18 pacientes com dados clínicos, laboratoriais e/ou 
epidemiológicos sugestivos de bartonelose foram submetidas a três 
amplificações duplas para a detecção de fragmento da proteína de choque 
térmico de 60-kDa (HSP), do espaçador interno 16S-23S rRNA (ITS) e da 
proteína de divisão celular (FtsZ) de Bartonella henselae, para melhorar 
a detecção em amostras clínicas. Na primeira amplificação, uma, quatro 
e cinco amostras, respectivamente, foram positivas pelo HSP (4,3%), 
FtsZ (17,4%) e pelo ITS (21,7%). Com a segunda amplificação foram 
identificadas seis amostras positivas pelo nested-HSP (26%), oito pelo 
nested-ITS (34,8%) e 18 pelo nested- FtsZ (78,2%), correspondentes a 10 
amostras de sangue periférico, cinco biópsias de linfonodos, duas biópsias 
de pele e um aspirado de gânglio. A nested-FtsZ foi mais sensível que 
a nested-HSP e a nested-ITS (p < 0,0001), possibilitando a detecção de 
DNA de Bartonella henselae em 15 de 18 pacientes (83,3%). No presente 
estudo, três nested-PCR, consideradas específicas para a amplificação 
da Bartonella henselae, foram desenvolvidas, porém somente a nested-
FtsZ não amplificou o DNA de Bartonella quintana. Concluímos que 
amplificações duplas aumentaram a detecção de DNA de B. henselae, e 
que a nested-FtsZ foi a mais sensível e a única específica para B. henselae 
em diferentes amostras biológicas. Como todas as amostras detectadas 
pelo HSP-nested e nested-ITS foram também pela nested-FtsZ, inferimos 
que, em nossa casuística, as infecções foram causadas por Bartonella 
henselae. A elevada positividade de amostras de sangue chamou a 
atenção para a utilização deste material biológico na investigação de 
bartoneloses, independentemente do estado imune dos pacientes. Este 
fato é importante no caso de pacientes criticamente enfermos e crianças 
pequenas para evitar procedimentos mais invasivos, como biópsias e 
punções de gânglios.
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